Plus   Neg

Medtronic Canada Receives Expanded Indication From Health Canada For Evolut TAVI Platform

Medtronic Canada ULC, a unit of Medtronic plc (MDT), has received a new expanded indication from Health Canada for Evolut Transcatheter Aortic Valve Implantation system. The company noted that its TAVI platform is currently the only system licensed for both bicuspid aortic valves, as well as all surgical risk categories in Canada. The expanded indication also allows patients with bicuspid aortic valves at extreme, high and intermediate risk of surgical mortality to also receive the procedure.

The expanded indication was based on clinical data from the global, randomized, multi-center Evolut Low Risk Trial, which evaluated three valve generations against surgical valve replacement in more than 1,400 patients.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration granted emergency use authorization (EUA) for the first and only clinical T cell-based test for patients to detect the unique T-cell signature specific to SARS-CoV-2, the virus that causes COVID-19. The test confirms recent or prior COVID-19 infection. Developed by Adaptive Biotechnologies, T-Detect COVID Test is a next generation sequencing based (NGS) test. AstraZeneca's one batch of Covid vaccine has been suspended by Austrian health authorities following reports of a death and an illness after receiving vaccination, reports said. The issues were reported in the district clinic of Zwettl in Lower Austria province. The Federal Office for Safety in Health Care in the country said the remaining stocks of the affected AstraZeneca/Oxford Covid-19 vaccine DuPont (DD) announced Monday that it has agreed to acquire Laird Performance Materials from with private equity firm Advent International for $2.3 billion. The company will use existing cash balances for the acquisition. The transaction is expected to close in the third quarter of 2021, subject to regulatory...
Follow RTT